MX260260B - Formulaciones semi-solidas para la administracion oral de taxoides. - Google Patents
Formulaciones semi-solidas para la administracion oral de taxoides.Info
- Publication number
- MX260260B MX260260B MXPA06000636A MX260260B MX 260260 B MX260260 B MX 260260B MX PA06000636 A MXPA06000636 A MX PA06000636A MX 260260 B MX260260 B MX 260260B
- Authority
- MX
- Mexico
- Prior art keywords
- taxoids
- semi
- oral administration
- solid formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291795A EP1498120A1 (en) | 2003-07-18 | 2003-07-18 | Semi-solid formulations for the oral administration of taxoids |
PCT/EP2004/008551 WO2005013968A1 (en) | 2003-07-18 | 2004-07-15 | Semi-solid formulations for the oral administration of taxoids |
Publications (2)
Publication Number | Publication Date |
---|---|
MXPA06000636A MXPA06000636A (es) | 2006-04-19 |
MX260260B true MX260260B (es) | 2008-09-04 |
Family
ID=33462258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA06000636 MX260260B (es) | 2003-07-18 | 2004-07-15 | Formulaciones semi-solidas para la administracion oral de taxoides. |
Country Status (21)
Country | Link |
---|---|
US (1) | US20050070496A1 (es) |
EP (2) | EP1498120A1 (es) |
JP (1) | JP5116306B2 (es) |
KR (1) | KR101143341B1 (es) |
CN (1) | CN1826110B (es) |
AR (1) | AR045996A1 (es) |
AT (1) | ATE388701T1 (es) |
AU (1) | AU2004262496B2 (es) |
BR (1) | BRPI0412759A (es) |
CA (1) | CA2532667A1 (es) |
DE (1) | DE602004012413T2 (es) |
DK (1) | DK1648440T3 (es) |
ES (1) | ES2303642T3 (es) |
HK (1) | HK1091743A1 (es) |
IL (1) | IL173110A (es) |
IN (1) | IN229997B (es) |
MX (1) | MX260260B (es) |
MY (1) | MY137965A (es) |
PT (1) | PT1648440E (es) |
TW (1) | TWI342774B (es) |
WO (1) | WO2005013968A1 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1498143A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
CA2652926A1 (en) * | 2006-05-26 | 2007-12-06 | Bayer Healthcare Llc | Drug combinations with substituted diaryl ureas for the treatment of cancer |
FR2922107B1 (fr) * | 2007-10-10 | 2010-02-26 | Aventis Pharma Sa | Nouvelles compositions a base de taxoides |
FR2924024B1 (fr) | 2007-11-27 | 2012-08-17 | Centre Nat Rech Scient | Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse |
FR2931152B1 (fr) * | 2008-05-16 | 2010-07-30 | Centre Nat Rech Scient | Nouveau systeme de transfert d'acide nucleique |
MY164086A (en) | 2009-10-29 | 2017-11-30 | Aventis Pharma Sa | Novel antitumoral use of cabazitaxel |
WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
CN103980232A (zh) * | 2014-06-05 | 2014-08-13 | 北京诺普德医药科技有限公司 | 10-乙酰基多西紫杉醇及其用途 |
KR101542364B1 (ko) * | 2014-10-31 | 2015-08-07 | 대화제약 주식회사 | 탁산을 포함하는 경구 투여용 약학 조성물 |
CN113698369A (zh) * | 2021-08-31 | 2021-11-26 | 无锡紫杉药业有限公司 | 一种除去卡巴他赛中特定单杂的方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3406497A1 (de) * | 1984-02-23 | 1985-09-05 | Mueller Bernhard Willi Werner | Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung |
US5272171A (en) * | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
JP3208517B2 (ja) * | 1992-07-01 | 2001-09-17 | ブリストル−マイヤーズ スクイブ カンパニー | 7,8−シクロプロパタキサン類 |
US5294637A (en) * | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
US5254580A (en) * | 1993-01-19 | 1993-10-19 | Bristol-Myers Squibb Company | 7,8-cyclopropataxanes |
US5478854A (en) * | 1992-10-01 | 1995-12-26 | Bristol-Myers Squibb Company | Deoxy taxols |
US5973160A (en) * | 1992-12-23 | 1999-10-26 | Poss; Michael A. | Methods for the preparation of novel sidechain-bearing taxanes |
US5646176A (en) * | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
IL131217A0 (en) * | 1998-03-10 | 2001-01-28 | Napro Biotherapeutics Inc | Novel methods and compositions for delivery of taxanes |
CN100341485C (zh) * | 1998-04-01 | 2007-10-10 | 斯凯伊药品加拿大公司 | 抗癌组合物 |
JP2003500368A (ja) * | 1999-05-24 | 2003-01-07 | ソーナス ファーマシューティカルス,インコーポレイテッド | 溶解度が不十分な薬剤のためのエマルジョンビヒクル |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
EP1365759A2 (en) * | 2001-01-18 | 2003-12-03 | PHARMACIA & UPJOHN COMPANY | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
WO2003045357A1 (en) * | 2001-11-27 | 2003-06-05 | Transform Pharmaceuticals, Inc. | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof |
WO2003053350A2 (en) * | 2001-12-20 | 2003-07-03 | Bristol-Myers Squibb Company | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability |
JP2005523295A (ja) * | 2002-03-01 | 2005-08-04 | ノバガリ、ファルマ、エスアー | 難溶性薬剤の自己乳化型薬物送達システム |
KR20090072980A (ko) * | 2007-12-28 | 2009-07-02 | 서울옵토디바이스주식회사 | 발광 다이오드 및 그 제조방법 |
-
2003
- 2003-07-18 EP EP03291795A patent/EP1498120A1/en not_active Ceased
-
2004
- 2004-07-15 IN IN198CH2006 patent/IN229997B/en unknown
- 2004-07-15 JP JP2006519899A patent/JP5116306B2/ja not_active Expired - Fee Related
- 2004-07-15 CN CN2004800207228A patent/CN1826110B/zh not_active Expired - Fee Related
- 2004-07-15 MX MXPA06000636 patent/MX260260B/es active IP Right Grant
- 2004-07-15 EP EP04741331A patent/EP1648440B1/en not_active Expired - Lifetime
- 2004-07-15 PT PT04741331T patent/PT1648440E/pt unknown
- 2004-07-15 AR ARP040102493A patent/AR045996A1/es not_active Application Discontinuation
- 2004-07-15 DK DK04741331T patent/DK1648440T3/da active
- 2004-07-15 BR BRPI0412759-5A patent/BRPI0412759A/pt not_active IP Right Cessation
- 2004-07-15 WO PCT/EP2004/008551 patent/WO2005013968A1/en active IP Right Grant
- 2004-07-15 KR KR1020067001136A patent/KR101143341B1/ko not_active IP Right Cessation
- 2004-07-15 CA CA002532667A patent/CA2532667A1/en not_active Abandoned
- 2004-07-15 DE DE602004012413T patent/DE602004012413T2/de not_active Expired - Lifetime
- 2004-07-15 AT AT04741331T patent/ATE388701T1/de not_active IP Right Cessation
- 2004-07-15 ES ES04741331T patent/ES2303642T3/es not_active Expired - Lifetime
- 2004-07-15 AU AU2004262496A patent/AU2004262496B2/en not_active Ceased
- 2004-07-16 TW TW093121233A patent/TWI342774B/zh not_active IP Right Cessation
- 2004-07-16 MY MYPI20042868A patent/MY137965A/en unknown
- 2004-07-19 US US10/894,163 patent/US20050070496A1/en not_active Abandoned
-
2006
- 2006-01-12 IL IL173110A patent/IL173110A/en not_active IP Right Cessation
- 2006-11-10 HK HK06112392.3A patent/HK1091743A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL173110A (en) | 2011-04-28 |
MY137965A (en) | 2009-04-30 |
US20050070496A1 (en) | 2005-03-31 |
DK1648440T3 (da) | 2008-07-14 |
IN2006CH00198A (es) | 2007-06-08 |
JP2009513558A (ja) | 2009-04-02 |
AU2004262496A1 (en) | 2005-02-17 |
EP1648440B1 (en) | 2008-03-12 |
EP1498120A1 (en) | 2005-01-19 |
CN1826110A (zh) | 2006-08-30 |
MXPA06000636A (es) | 2006-04-19 |
AR045996A1 (es) | 2005-11-23 |
PT1648440E (pt) | 2008-06-24 |
DE602004012413T2 (de) | 2009-03-12 |
CN1826110B (zh) | 2010-05-12 |
AU2004262496B2 (en) | 2009-02-05 |
HK1091743A1 (en) | 2007-01-26 |
JP5116306B2 (ja) | 2013-01-09 |
ATE388701T1 (de) | 2008-03-15 |
KR20060037370A (ko) | 2006-05-03 |
ES2303642T3 (es) | 2008-08-16 |
KR101143341B1 (ko) | 2012-05-24 |
TWI342774B (en) | 2011-06-01 |
WO2005013968A1 (en) | 2005-02-17 |
CA2532667A1 (en) | 2005-02-17 |
DE602004012413D1 (de) | 2008-04-24 |
BRPI0412759A (pt) | 2006-09-26 |
IL173110A0 (en) | 2006-06-11 |
EP1648440A1 (en) | 2006-04-26 |
IN229997B (es) | 2009-03-27 |
TW200517104A (en) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091743A1 (en) | Semi-solid formulations for the oral administration of taxoids | |
EP1622540A4 (en) | FORMULATIONS FOR CELL-PLAN-DEPENDENT CANCER | |
ZA200606174B (en) | Multiparticulate formulations for oral delivery | |
IL173571A0 (en) | Injectable, oral, or topical sustained release pharmaceutical formulations | |
IL172824A0 (en) | Pharmaceutical formulations | |
GB0302671D0 (en) | Pharmaceutical formulations | |
DK1615646T4 (da) | Farmaceutiske formuleringer, der indeholder methylnaltrexon | |
GB0210397D0 (en) | Pharmaceutical formulations | |
HK1087399A1 (en) | Pharmaceutical formulations comprising highly purebases of 3, 3-giphenylpropylamine monoesters | |
HK1089951A1 (en) | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids | |
IL175303A0 (en) | Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same | |
GB0302672D0 (en) | Pharmaceutical formulations | |
SI1592457T1 (sl) | Konjugat folat-vinblastin kot zdravilo | |
WO2004087101A3 (en) | Oral formulations of cladribine | |
HK1092715A1 (en) | Melt-formulated, multi-particulate oral dosage form | |
IL173111A0 (en) | Semi-solid formulations containing azetidine derivatives | |
GB0316341D0 (en) | Pharmaceutical formulations | |
ITRM20030074A0 (it) | Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci. | |
EP1361866A4 (en) | EMULSIONS AS SOLID DOSAGE FORMS FOR ORAL ADMINISTRATION | |
ZA200204905B (en) | Improved pharmaceutical dental formulations. | |
ITRM20020357A0 (it) | Composizione liquida per la somministrazione orale di lorazepam. | |
ZA200803553B (en) | Oral formulations comprising 3'-azidonucleosides | |
GB0316335D0 (en) | Pharmaceutical formulations | |
HU0401927D0 (en) | New oral taxane formulations | |
GB0326642D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |